Preliminary results of a phase I/II study of the humanized anti-CD20 antibody IMMU-106 (hA20) in patients with relapsed non-Hodgkin lymphoma

Sonia Cunningham, Sabeeha Muneer, Aarati Ranganathan, Latha Shivakumar, Sagar Lonial, Tariq Mughal, James O. Armitage

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Preliminary results of a phase I/II study of the humanized anti-CD20 antibody IMMU-106 (hA20) in patients with relapsed non-Hodgkin lymphoma'. Together they form a unique fingerprint.